IFNG and diabetes mellitus: A possible cellular target of IFN-γ might be DCs because transfer of healthy splenic DC ex vivo stimulated with IFN-γ significantly suppressed clinical symptoms of EAE and prevented diabetes onset in NOD mice [49, 85, 86].